CWA Asset Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.94M Buy
38,429
+8,447
+28% +$989K 0.15% 145
2026
Q1
$3.61M Sell
29,982
-25,610
-46% -$2.96M 0.12% 177
2025
Q4
$5.85M Buy
55,592
+25,736
+86% +$2.42M 0.21% 100
2025
Q3
$2.51M Sell
29,856
-7,182
-19% -$592K 0.09% 193
2025
Q2
$2.93M Sell
37,038
-2,386
-6% -$190K 0.12% 160
2025
Q1
$3.54M Buy
39,424
+13,075
+50% +$1.22M 0.17% 125
2024
Q4
$2.62M Sell
26,349
-11,332
-30% -$1.17M 0.13% 145
2024
Q3
$4.28M Buy
+37,681
New +$4.48M 0.23% 93
2024
Q1
$2.17M Buy
16,439
+1,275
+8% +$157K 0.13% 141
2023
Q4
$1.65M Buy
15,164
+2,815
+23% +$292K 0.11% 130
2023
Q3
$1.27M Sell
12,349
-1,077
-8% -$116K 0.09% 129
2023
Q2
$1.55M Buy
13,426
+684
+5% +$77.7K 0.11% 117
2023
Q1
$1.36M Sell
12,742
-351
-3% -$37.9K 0.1% 117
2022
Q4
$1.45M Sell
13,093
-2,702
-17% -$276K 0.12% 123
2022
Q3
$1.36M Buy
15,795
+1,267
+9% +$113K 0.13% 103
2022
Q2
$1.32M Buy
14,528
+1,486
+11% +$132K 0.12% 110
2022
Q1
$1.07M Buy
13,042
+4,111
+46% +$324K 0.08% 126
2021
Q4
$684K Sell
8,931
-1,284
-13% -$102K 0.05% 159
2021
Q3
$767K Sell
10,215
-72,940
-88% -$5.55M 0.06% 146
2021
Q2
$6.49M Buy
83,155
+9,756
+13% +$726K 0.53% 55
2021
Q1
$5.4M Sell
73,399
-77,827
-51% -$5.74M 0.49% 62
2020
Q4
$11.8M Buy
151,226
+16,367
+12% +$1.25M 1.24% 26
2020
Q3
$10.7M Buy
134,859
+25,727
+24% +$2.02M 1.43% 21
2020
Q2
$8.05M Sell
109,132
-4,520
-4% -$340K 1.41% 21
2020
Q1
$8.34M Buy
113,652
+10,402
+10% +$818K 1.59% 22
2019
Q4
$8.96M Sell
103,250
-567
-0.5% -$46.6K 1.44% 18
2019
Q3
$8.34M Buy
103,817
+9,190
+10% +$737K 1.34% 21
2019
Q2
$7.57M Buy
94,627
+10,576
+13% +$810K 1.3% 18
2019
Q1
$6.67M Buy
84,051
+12,581
+18% +$941K 1.29% 20
2018
Q4
$5.21M Buy
71,470
+7,403
+12% +$523K 1.21% 20
2018
Q3
$4.34M Buy
64,067
+4,819
+8% +$307K 0.96% 39
2018
Q2
$3.43M Buy
59,248
+4,120
+7% +$232K 0.8% 48
2018
Q1
$2.87M Buy
55,128
+7,759
+16% +$419K 0.71% 54
2017
Q4
$2.54M Buy
47,369
+13,564
+40% +$752K 0.67% 58
2017
Q3
$2.06M Buy
33,805
+1,900
+6% +$115K 0.6% 62
2017
Q2
$1.95M Buy
31,905
+4,165
+15% +$254K 0.62% 65
2017
Q1
$1.68M Buy
27,740
+2,763
+11% +$168K 0.57% 60
2016
Q4
$1.4M Buy
24,977
+5,551
+29% +$325K 0.6% 59
2016
Q3
$1.16M Buy
19,426
+2,680
+16% +$157K 0.64% 52
2016
Q2
$921K Buy
16,746
+3,293
+24% +$175K 0.56% 57
2016
Q1
$679K Buy
13,453
+1,713
+15% +$83.9K 0.69% 47
2015
Q4
$592K Buy
+11,740
New +$592K 0.67% 52

Other funds holding MRK

CWA Asset Management Group's MRK Position: Q2 2026 in Review

CWA Asset Management Group increased its Merck (MRK) stake by 28% in Q2 2026, buying an estimated $989K and bringing the position to 38,429 shares worth $4.94M. The position accounts for 0.15% of the portfolio, ranked #145.

CWA Asset Management Group first reported a position in MRK in Q4 2015 and has held it in 42 quarters since. The position peaked at $11.8M in Q4 2020. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • CWA Asset Management Group held 38,429 shares of Merck worth $4.94M as of Q2 2026.
  • CWA Asset Management Group bought 8,447 Merck shares in Q2 2026, an estimated $989K.
  • Merck made up 0.15% of CWA Asset Management Group's portfolio in Q2 2026, its #145 holding.
  • CWA Asset Management Group first reported a position in Merck in Q4 2015 and has held it in 42 quarters since.
  • CWA Asset Management Group's Merck position peaked at $11.8M in Q4 2020.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.